CAS: 346692-04-4
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
N-(4-butylphenyl)-4-fluorobenzenesulfonamide REF: AN-AG00CNHBCAS: 346692-04-4 | ≥98%(HPLC) | 146.00 €~658.00 € | Tue 07 May 24 | |
DC260126 REF: TM-T7127CAS: 346692-04-4 | 98% | 54.00 €~213.00 € | Tue 14 May 24 | |
DC260126 REF: 3D-WNA69204CAS: 346692-04-4 | Min. 95% | To inquire | Tue 18 Jun 24 |
N-(4-butylphenyl)-4-fluorobenzenesulfonamide
CAS:346692-04-4
Formula:
C16H18FNO2S
Purity:
≥98%(HPLC)
Molecular weight:
307.3830
Ref: AN-AG00CNHB
1g | 553.00 € | |
100mg | 146.00 € | |
250mg | 245.00 € |
Estimated delivery in United States, on Tuesday 7 May 2024
DC260126
CAS:346692-04-4
DC260126 is a small-molecule antagonist of FFA1 (GPR40)
Formula:
C16H18FNO2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
307.38
Ref: TM-T7127
5mg | 54.00 € | |
10mg | 71.00 € | |
25mg | 139.00 € | |
50mg | 213.00 € | |
1ml*10 (DMSO) | 58.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
DC260126
CAS:346692-04-4
DC260126 is an investigational drug for the treatment of human breast cancer. DC260126 is a …
Formula:
C16H18FNO2S
Purity:
Min. 95%
Molecular weight:
307.38 g/mol
Ref: 3D-WNA69204
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Jun 2024